In liver diseases, such as NAFLD and cirrhosis, PCNA expression is increased, leading to excessive and uncontrolled proliferation of damaged tissue to replace damaged tissue and liver fibrosis. This evidence concerns the gene PCNA and metabolic dysfunction-associated steatotic liver disease.